Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Liang Liu, Jimmy Ruiz, Stacey S. O’Neill, Stefan C. Grant, W. Jeffrey Petty, Meng Yang, Kexin Chen, Umit Topaloglu, Boris Pasche, Wei Zhang

ABSTRACT

Mutations in polymerase ε (POLE) confer favorable prognosis and outcomes in various cancer types, but their role in non-small cell lung cancer (NSCLC) is unknown. Utilizing the data of 513 patients with adenocarcinoma (LUAD) and 497 patients with squamous cell carcinoma (LUSC) from The Cancer Genome Atlas (TCGA) cohort, we tested the prognostic value of POLE mutations and programmed cell death ligand 1 (PD-L1) expression in the two main subtypes of NSCLC. POLE mutation is a favorable biomarker for the improved overall survival (OS) of the LUSC patients (P = 0.033, 28 mutant vs. 469 wildtype patients), but not that of the LUAD patients (P = 0.12, 31 mutant vs. 482 wildtype patients). POLE-mutant LUAD patients with high expression of PD-L1 (Mut-High, n = 6) exhibited improved OS (P = 0.024) when compared to POLE-mutant patients with low PD-L1 expression (Mut-Low, n = 24) and other patients without POLE mutation (n = 476). This benefit was not due to the high content of the tumor infiltrating lymphocytes. Instead, the antitumor immune response was activated in Mut-High patients so that these patients were likely responding more effectively to immuno-oncology (IO) treatments; whereas genes involved with metabolic pathways were enriched in Mut-Low group, which may cause the decreased OS of these patients. Our study sheds light on the molecular basis of NSCLC and adds to our understanding of responses to chemotherapy and IO therapy. More... »

PAGES

81

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12943-018-0832-y

DOI

http://dx.doi.org/10.1186/s12943-018-0832-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103231196

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29650000


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Department of Cancer Biology, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Liang", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Internal Medicine-Section of Hematology and Oncology, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruiz", 
        "givenName": "Jimmy", 
        "id": "sg:person.01111602451.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111602451.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest University", 
          "id": "https://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Laboratory Medicine and Pathology, Wake Forest School of Medicine, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O\u2019Neill", 
        "givenName": "Stacey S.", 
        "id": "sg:person.011446465424.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011446465424.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Internal Medicine-Section of Hematology and Oncology, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grant", 
        "givenName": "Stefan C.", 
        "id": "sg:person.0736414074.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736414074.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Internal Medicine-Section of Hematology and Oncology, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petty", 
        "givenName": "W. Jeffrey", 
        "id": "sg:person.0645036312.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645036312.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Department of Cancer Biology, 27157, Winston Salem, NC, USA", 
            "Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, 300060, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Meng", 
        "id": "sg:person.0615466467.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615466467.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, 300060, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Kexin", 
        "id": "sg:person.014472326277.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014472326277.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Department of Cancer Biology, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Topaloglu", 
        "givenName": "Umit", 
        "id": "sg:person.01250123730.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250123730.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Department of Cancer Biology, 27157, Winston Salem, NC, USA", 
            "Internal Medicine-Section of Hematology and Oncology, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pasche", 
        "givenName": "Boris", 
        "id": "sg:person.0667063306.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667063306.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA", 
            "Department of Cancer Biology, 27157, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Wei", 
        "id": "sg:person.012724545020.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012724545020.23"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature12113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004984574", 
          "https://doi.org/10.1038/nature12113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature11252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010619765", 
          "https://doi.org/10.1038/nature11252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/molbev/msn294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028609581"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/ijms17081320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031969792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.66.9929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037103051"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.aaa1348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062665078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.aaa1348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062665078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-16-3146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083854444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/imt-2016-0150", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085180120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1613493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086112913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1613493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086112913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.34.15_suppl.11523", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106841192"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "Mutations in polymerase \u03b5 (POLE) confer favorable prognosis and outcomes in various cancer types, but their role in non-small cell lung cancer (NSCLC) is unknown. Utilizing the data of 513 patients with adenocarcinoma (LUAD) and 497 patients with squamous cell carcinoma (LUSC) from The Cancer Genome Atlas (TCGA) cohort, we tested the prognostic value of POLE mutations and programmed cell death ligand 1 (PD-L1) expression in the two main subtypes of NSCLC. POLE mutation is a favorable biomarker for the improved overall survival (OS) of the LUSC patients (P\u2009=\u00a00.033, 28 mutant vs. 469 wildtype patients), but not that of the LUAD patients (P\u2009=\u00a00.12, 31 mutant vs. 482 wildtype patients). POLE-mutant LUAD patients with high expression of PD-L1 (Mut-High, n\u00a0=\u20096) exhibited improved OS (P\u2009=\u00a00.024) when compared to POLE-mutant patients with low PD-L1 expression (Mut-Low, n\u00a0=\u200924) and other patients without POLE mutation (n\u00a0=\u2009476). This benefit was not due to the high content of the tumor infiltrating lymphocytes. Instead, the antitumor immune response was activated in Mut-High patients so that these patients were likely responding more effectively to immuno-oncology (IO) treatments; whereas genes involved with metabolic pathways were enriched in Mut-Low group, which may cause the decreased OS of these patients. Our study sheds light on the molecular basis of NSCLC and adds to our understanding of responses to chemotherapy and IO therapy.", 
    "genre": "non_research_article", 
    "id": "sg:pub.10.1186/s12943-018-0832-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438796", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1031030", 
        "issn": [
          "1476-4598"
        ], 
        "name": "Molecular Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1", 
    "pagination": "81", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12943-018-0832-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103231196"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "255fca6b03b8a543d803e41b2a6433b91bf3fa3cf6f6158f1329c11d9cdf2e22"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101147698"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29650000"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12943-018-0832-y", 
      "https://app.dimensions.ai/details/publication/pub.1103231196"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-16T06:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000377_0000000377/records_106813_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12943-018-0832-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12943-018-0832-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12943-018-0832-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12943-018-0832-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12943-018-0832-y'


 

This table displays all metadata directly associated to this object as RDF triples.

175 TRIPLES      21 PREDICATES      39 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12943-018-0832-y schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nd73d6e1233874cc4bb1160eb213f7fff
4 schema:citation sg:pub.10.1038/nature11252
5 sg:pub.10.1038/nature12113
6 https://doi.org/10.1056/nejmoa1613493
7 https://doi.org/10.1093/molbev/msn294
8 https://doi.org/10.1126/science.aaa1348
9 https://doi.org/10.1158/1078-0432.ccr-16-3146
10 https://doi.org/10.1200/jco.2016.34.15_suppl.11523
11 https://doi.org/10.1200/jco.2016.66.9929
12 https://doi.org/10.2217/imt-2016-0150
13 https://doi.org/10.3390/ijms17081320
14 schema:datePublished 2018-12
15 schema:datePublishedReg 2018-12-01
16 schema:description Mutations in polymerase ε (POLE) confer favorable prognosis and outcomes in various cancer types, but their role in non-small cell lung cancer (NSCLC) is unknown. Utilizing the data of 513 patients with adenocarcinoma (LUAD) and 497 patients with squamous cell carcinoma (LUSC) from The Cancer Genome Atlas (TCGA) cohort, we tested the prognostic value of POLE mutations and programmed cell death ligand 1 (PD-L1) expression in the two main subtypes of NSCLC. POLE mutation is a favorable biomarker for the improved overall survival (OS) of the LUSC patients (P = 0.033, 28 mutant vs. 469 wildtype patients), but not that of the LUAD patients (P = 0.12, 31 mutant vs. 482 wildtype patients). POLE-mutant LUAD patients with high expression of PD-L1 (Mut-High, n = 6) exhibited improved OS (P = 0.024) when compared to POLE-mutant patients with low PD-L1 expression (Mut-Low, n = 24) and other patients without POLE mutation (n = 476). This benefit was not due to the high content of the tumor infiltrating lymphocytes. Instead, the antitumor immune response was activated in Mut-High patients so that these patients were likely responding more effectively to immuno-oncology (IO) treatments; whereas genes involved with metabolic pathways were enriched in Mut-Low group, which may cause the decreased OS of these patients. Our study sheds light on the molecular basis of NSCLC and adds to our understanding of responses to chemotherapy and IO therapy.
17 schema:genre non_research_article
18 schema:inLanguage en
19 schema:isAccessibleForFree true
20 schema:isPartOf N8c8f7441145943888d57275a75dfaec6
21 Nc4a5ef0d31474ef48f36c16ccb8f8173
22 sg:journal.1031030
23 schema:name Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1
24 schema:pagination 81
25 schema:productId N499f076b348c4aa7996d639b17b63c11
26 N4c2476300ecf4a21b073103ea40cde38
27 N4ccc0ef652d74c78b959e4d1c88d1124
28 N74adf8c8e0824d7597b48ba6b90ce1e5
29 Nfb986d5cb19742e48f6bfb2192daf7f7
30 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103231196
31 https://doi.org/10.1186/s12943-018-0832-y
32 schema:sdDatePublished 2019-04-16T06:22
33 schema:sdLicense https://scigraph.springernature.com/explorer/license/
34 schema:sdPublisher N39a5e2bfad034bd4a1300ee1169219ee
35 schema:url http://link.springer.com/10.1186%2Fs12943-018-0832-y
36 sgo:license sg:explorer/license/
37 sgo:sdDataset articles
38 rdf:type schema:ScholarlyArticle
39 N1cd20d88d4f847a380c3b1a8184c8655 rdf:first sg:person.0736414074.52
40 rdf:rest N8e02fd3e29d34f63b8af2fadf2fe3eeb
41 N2741065f0b3b48bdb5d8f0e028ddafa4 rdf:first sg:person.0667063306.79
42 rdf:rest N70c74210bd964223b49d5201cc4b906b
43 N39a5e2bfad034bd4a1300ee1169219ee schema:name Springer Nature - SN SciGraph project
44 rdf:type schema:Organization
45 N3faf345d3ad5455a81af701ab02bf70f rdf:first sg:person.0615466467.33
46 rdf:rest Ne31c64f4183f49a585b873dc2681bc98
47 N499f076b348c4aa7996d639b17b63c11 schema:name nlm_unique_id
48 schema:value 101147698
49 rdf:type schema:PropertyValue
50 N4c2476300ecf4a21b073103ea40cde38 schema:name pubmed_id
51 schema:value 29650000
52 rdf:type schema:PropertyValue
53 N4ccc0ef652d74c78b959e4d1c88d1124 schema:name dimensions_id
54 schema:value pub.1103231196
55 rdf:type schema:PropertyValue
56 N550c6cb23ac0424fa68d29542ee7cdd9 rdf:first sg:person.01250123730.54
57 rdf:rest N2741065f0b3b48bdb5d8f0e028ddafa4
58 N70c74210bd964223b49d5201cc4b906b rdf:first sg:person.012724545020.23
59 rdf:rest rdf:nil
60 N74adf8c8e0824d7597b48ba6b90ce1e5 schema:name readcube_id
61 schema:value 255fca6b03b8a543d803e41b2a6433b91bf3fa3cf6f6158f1329c11d9cdf2e22
62 rdf:type schema:PropertyValue
63 N8b89a3bf3c2b445c95e75112583fbbf6 rdf:first sg:person.01111602451.43
64 rdf:rest Nc01c186fe95a4d5d986fc42a1586beb4
65 N8c8f7441145943888d57275a75dfaec6 schema:issueNumber 1
66 rdf:type schema:PublicationIssue
67 N8e02fd3e29d34f63b8af2fadf2fe3eeb rdf:first sg:person.0645036312.23
68 rdf:rest N3faf345d3ad5455a81af701ab02bf70f
69 Nc01c186fe95a4d5d986fc42a1586beb4 rdf:first sg:person.011446465424.36
70 rdf:rest N1cd20d88d4f847a380c3b1a8184c8655
71 Nc4a5ef0d31474ef48f36c16ccb8f8173 schema:volumeNumber 17
72 rdf:type schema:PublicationVolume
73 Nd73d6e1233874cc4bb1160eb213f7fff rdf:first Ne76062030a8b4c78b47373b61540dd45
74 rdf:rest N8b89a3bf3c2b445c95e75112583fbbf6
75 Ne31c64f4183f49a585b873dc2681bc98 rdf:first sg:person.014472326277.94
76 rdf:rest N550c6cb23ac0424fa68d29542ee7cdd9
77 Ne76062030a8b4c78b47373b61540dd45 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
78 schema:familyName Liu
79 schema:givenName Liang
80 rdf:type schema:Person
81 Nfb986d5cb19742e48f6bfb2192daf7f7 schema:name doi
82 schema:value 10.1186/s12943-018-0832-y
83 rdf:type schema:PropertyValue
84 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
85 schema:name Medical and Health Sciences
86 rdf:type schema:DefinedTerm
87 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
88 schema:name Oncology and Carcinogenesis
89 rdf:type schema:DefinedTerm
90 sg:grant.2438796 http://pending.schema.org/fundedItem sg:pub.10.1186/s12943-018-0832-y
91 rdf:type schema:MonetaryGrant
92 sg:journal.1031030 schema:issn 1476-4598
93 schema:name Molecular Cancer
94 rdf:type schema:Periodical
95 sg:person.01111602451.43 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
96 schema:familyName Ruiz
97 schema:givenName Jimmy
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111602451.43
99 rdf:type schema:Person
100 sg:person.011446465424.36 schema:affiliation https://www.grid.ac/institutes/grid.241167.7
101 schema:familyName O’Neill
102 schema:givenName Stacey S.
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011446465424.36
104 rdf:type schema:Person
105 sg:person.01250123730.54 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
106 schema:familyName Topaloglu
107 schema:givenName Umit
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250123730.54
109 rdf:type schema:Person
110 sg:person.012724545020.23 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
111 schema:familyName Zhang
112 schema:givenName Wei
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012724545020.23
114 rdf:type schema:Person
115 sg:person.014472326277.94 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
116 schema:familyName Chen
117 schema:givenName Kexin
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014472326277.94
119 rdf:type schema:Person
120 sg:person.0615466467.33 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
121 schema:familyName Yang
122 schema:givenName Meng
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615466467.33
124 rdf:type schema:Person
125 sg:person.0645036312.23 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
126 schema:familyName Petty
127 schema:givenName W. Jeffrey
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645036312.23
129 rdf:type schema:Person
130 sg:person.0667063306.79 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
131 schema:familyName Pasche
132 schema:givenName Boris
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667063306.79
134 rdf:type schema:Person
135 sg:person.0736414074.52 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
136 schema:familyName Grant
137 schema:givenName Stefan C.
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736414074.52
139 rdf:type schema:Person
140 sg:pub.10.1038/nature11252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010619765
141 https://doi.org/10.1038/nature11252
142 rdf:type schema:CreativeWork
143 sg:pub.10.1038/nature12113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004984574
144 https://doi.org/10.1038/nature12113
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1056/nejmoa1613493 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086112913
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1093/molbev/msn294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028609581
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1126/science.aaa1348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062665078
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1158/1078-0432.ccr-16-3146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083854444
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1200/jco.2016.34.15_suppl.11523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106841192
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1200/jco.2016.66.9929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037103051
157 rdf:type schema:CreativeWork
158 https://doi.org/10.2217/imt-2016-0150 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085180120
159 rdf:type schema:CreativeWork
160 https://doi.org/10.3390/ijms17081320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031969792
161 rdf:type schema:CreativeWork
162 https://www.grid.ac/institutes/grid.241167.7 schema:alternateName Wake Forest University
163 schema:name Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA
164 Laboratory Medicine and Pathology, Wake Forest School of Medicine, 27157, Winston Salem, NC, USA
165 rdf:type schema:Organization
166 https://www.grid.ac/institutes/grid.411918.4 schema:alternateName Tianjin Medical University Cancer Institute and Hospital
167 schema:name Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA
168 Department of Cancer Biology, 27157, Winston Salem, NC, USA
169 Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, 300060, Tianjin, People’s Republic of China
170 rdf:type schema:Organization
171 https://www.grid.ac/institutes/grid.412860.9 schema:alternateName Wake Forest Baptist Medical Center
172 schema:name Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, 27157, Winston Salem, NC, USA
173 Department of Cancer Biology, 27157, Winston Salem, NC, USA
174 Internal Medicine-Section of Hematology and Oncology, 27157, Winston Salem, NC, USA
175 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...